These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11716 related articles for article (PubMed ID: 1270047)

  • 1. [Immunology of malignant melanomas].
    Schieferstein G
    Fortschr Med; 1976 May; 94(14):833-7. PubMed ID: 1270047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation pattern of hamster melanoma cells cultured in diffusion chambers in pre-immunized hosts.
    Schieferstein G; Laerum OD
    Arch Dermatol Forsch; 1975; 251(3):169-80. PubMed ID: 1115522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antigenicity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):641-4. PubMed ID: 7192976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of human malignant melanoma.
    Lewis MG
    Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and spontaneous regression of swine melanoma: relationship of in vitro leukocyte reactivity.
    Berkelhammer J; Ensign BM; Hook RR; Hecker CJ; Smith GD; Oxenhandler RW
    J Natl Cancer Inst; 1982 Mar; 68(3):461-8. PubMed ID: 6950174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of macrophage IL-10 and NO secretion in the cytotoxicity against transplantable melanomas in relation to the progression of these tumours.
    Kozłowska K; Cichorek M; Zarzeczna M
    Folia Morphol (Warsz); 2002; 61(3):127-31. PubMed ID: 12416926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology and immunotherapy of human malignant melanoma.
    Bystryn JC
    Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proceeding a protein factor re-establishing the contact-inhibition of hamster melanoma cells in vitro].
    Knecht M; Lipkin G
    Dermatologica; 1974; 148(5):275. PubMed ID: 4418288
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model.
    Wolnicka-Glubisz A; Noonan FP
    Photochem Photobiol Sci; 2006 Feb; 5(2):254-60. PubMed ID: 16465311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
    Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
    J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis caused by cytotoxic immune response to cutaneous malignant melanoma in swine: destruction of uveal melanocytes during tumor regression.
    Lentz KJ; Burns RP; Loeffler K; Feeney-Burns L; Berkelhammer J; Hook RR
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1063-9. PubMed ID: 6874271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo.
    Liu X; Chen D; Xie L; Zhang R
    J Pharm Pharmacol; 2002 Aug; 54(8):1083-9. PubMed ID: 12195822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and metastasis of hamster melanoma following transplantation into athymic mice.
    Schleicher RL; Green AW; Beattie CW
    Cancer Res; 1987 Aug; 47(16):4465-70. PubMed ID: 3607776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific immune reactivity in patients with malignant melanoma (author's transl)].
    Poljak-Blazi M; Montani D; Ferle-Vidović A; Boranić M
    Lijec Vjesn; 1977 Dec; 99(12):735-8. PubMed ID: 607047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 586.